Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2025.First Quarter HighlightsNet revenues of $170.5 million for the first quarterGAAP net income of $25.3 million, or $0.51 per share, for the first quarterAdjusted non-GAAP net income of $36.9 million, or $0.74 per share, for the first quarterDr. Jack Zhang, Amphastar's President and Chief Executive Officer,...
Read more








